Promoters of FMCG major Dabur, the Burman family, and founders of UK-based ‘Healthcare at Home’ plan to invest Rs 200 crore over 5 years to expand operations of their recently formed Indian joint venture firm.
The Burmans hold 65 per cent stake in the JV - Health Care At Home India (HCAH) - and the rest is held by Gareth Jones and Charles Walsh, the founders of HAH, UK.
“We have committed a capital of Rs 200 crore for the next 3-5 years to expand our operations in the country,” HCAH India Chief Executive Officer Vivek Srivastava told PTI.
The company, which started operations in Delhi/NCR region about six months ago, is aiming to have a pan-India presence in the next two years, he added.
“We are starting operations in Chandigarh next month. It will cater to other markets like Punjab, Haryana and Himachal Pradesh. It will be followed by other cities like Mumbai, Bangalore and Hyderabad,” Mr. Srivastava said.
Giving details about the investment over the next five years, Mr. Srivastava said the majority of the capital will go into establishment of IT infrastructure, hiring, training and marketing.
When asked about the expectations of the Burman family from the new venture, Gaurav Burman, said: “Healthcare is a sector in which we have heritage and great interest. It is a sector in which India is at its early stages of growth and we are keen to invest aggressively in this sector.”
The JV works with corporate hospitals and doctors to offer critical healthcare services in oncology, pulmonology, post operative care and critical care. It also aims to enter other services such as maternity and aged care.
“With this JV, we are introducing this affordable but high quality at home healthcare service,” Health Care at Home India Chairman Gareth Jones said.
HAH, set up in 1992, has turnover in excess of 1 billion pounds (Rs 10,000 crore). It has been involved in developing and providing patient-centric homecare services in the UK, Europe and Australia.
